From looking at the program, there were only 2 accepted oral papers for the Cancer of the Pancreas session - the rest are invited or panel discussions.
So,that's excellent.
Also I note a panel discussion on borderline resectable/non-resectable definitions, which would go a long way toward addressing the appropriate patient groups for oncosil treatment in future studies.
From looking at the program, there were only 2 accepted oral...
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.001(12.5%) |
Mkt cap ! $30.58M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.8¢ | $76.51K | 8.942M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 6748135 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 5953875 | 4 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |